Oxygen is life!

Welcome to Oxyven

Oxyven – our company

The Oxyven-Device Dr. H.S. Regelsberger GmbH & Co. KG was founded in the year 1975. Dr. med. Regelsberger (neurologist/neurosurgeon from Detmold) has done intensive research on intravenous application of minute amounts of oxygen and has been able to determine its therapeutic effect. Thus, it became his great desire to standardize the implementation of this particular application with its sophisticated device.

Application methods have been developed in continuous stages to make the safety related highly sophisticated oxygen-application device from company Helkueb OHG available.

It is dose dependable and best suitable for flow–monitoring intravenous oxygen-insufflation in the medicine sector. Optimum support for our customers in the supervision of the practical application of this specific application device in practice is of particular importance to us. In this specific way, the customers receive a detailed instruction in their practice.

This specified therapy founded by Dr. med. Regelsberger has been implemented by over 1000 therapists - according to details of the international society for oxygen-nierungstherapie e.V. (www.oxyvenierung.com).

Applimed O² 1000

The intravenous oxygen application

You can get indications and details to the thirty year research development in the therapy method of the intravenous oxygen-application carried out by Dr. med. H.S. Regelsberger in

would you please inform yourself in the appropriate regulations, panels or by the International Society of Oxyvenierungstherapie e.V.
www.oxyvenierung.com

Applimed-O2 1000 controls the exact and reliable application of medical oxygen in the intravenous method in a dosage in a range between 1 to 2ml/min. Oxygen is a very important component in complementary medicine.

Oxygen leads to the intensified formation of the blood flow and antithrombotic hormone Prostacyclin. It is formed in the lung endothelium. Result is a strong vascular dilation in the complete body structure (an average increase of Prostacycline of more than 800%; according to an article written by Prof. Dr. J.C. Frölich - Hannover Medical School).

An eosinophilia is initiated by applying oxygen. The eosinophilic granulocytes are capable of forming the 15-lipoxygenase-1, with oxygen release from the arachidonic acid cascade. The leukotriene synthesis is being blocked by this process. The anti-inflammatory effect has been confirmed by the work of Prof. Dr. sc. Med. Hartmut Kühn - Charite Berlin. Further literature is available through our: Contact.

Exhibitions and seminars


31. März 2021 Mi. 18.30 – 20.00

ONLINE-SEMINAR: Volkskrankheit Bluthochdruck? Wie Sie erfolgreich behandeln können.
Referent: Dr. med. Dirk Wiechert, Allgemeinmedizin, Bremen
Online-Anmeldung

please refer: https://www.igafev.com/veranstaltungen.html


A: 16-17.04.2021 / B: 28-29.05.2021

Klinische Mitochondrienmedizin und Umweltmedizin 2021

please refer: https://www.mito-medizin.de/curriculum-2021/

24. April 2021 10:00-16:00

M E T A B O L O M: Wie das Mikrobiom die Gesundheit des Menschen beeinflusst
Holiday Inn München-Unterhaching
Inselkammerstr. 7-9
82008 Unterhaching

Einladung / Anmeldeformular


29. Mai - 5. Juni 2021

Akademie am Meer: XX. Warnemünder Woche
HOTEL NEPTUN
Seestraße 19
18119 Rostock-Warnemünde

Programm


August 2021

28.- 29. August 2021

1. Internationaler O2 – Kongress

Elvis-Presley-Platz 1
61231 Bad Nauheim

Anmeldeformular


11. September 2021 9:00 bis 18:00 Uhr

Zertifizierungskurs für Oxyvenierung
Veranstaltungsort: Vital-Center
Kaarster Straße 250
41462 Neuss
Leitung: Dr. med. Dirk Wiechert , HP Stefan Marzinowski

Anmeldeformular

Contact

Should you need further information to our oxygen-application and to our oxyven therapy according to Dr. med. Regelsberger. – Just leave us a message; we will enjoy supporting you.

Oxyven-Geräte
Dr. med. H.S. Regelsberger GmbH & Co. KG

Brookstr. 31 A
D-49811 Lingen

Telephone: +49 (0) 591 / 901 108-0
Fax: +49 (0) 591 / 901 108-20

E-Mail: info@oxyven.de

* required fields